Siemens to Replace Healthineers CFO in Preparation for Listing Post author:Sam Post published:November 8, 2017 Post category:BioPharma The public listing that is expected to value the business at around $46 billion. Source: BioSpace You Might Also Like Deal Spree Continues as Celgene Nabs Juno in $9B Deal January 21, 2018 <b>Advantis Corp.</b> Expanding National Reach June 6, 2017 Bay Area's Relievant Medsystems Names a New CEO September 20, 2017
